{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:22:26Z","timestamp":1749406946416},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/qai.0b013e31818d5c1c","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T08:11:07Z","timestamp":1227255067000},"page":"532-537","source":"Crossref","is-referenced-by-count":13,"title":["Long-Term Effectiveness of Diagnosing and Treating Latent Tuberculosis Infection in a Cohort of HIV-Infected and At-Risk Injection Drug Users"],"prefix":"10.1097","volume":"49","author":[{"given":"Jonathan E","family":"Golub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquie","family":"Astemborski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti H","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vlahov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210131","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"R2-11-20210131","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska.","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"R3-11-20210131","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons.","volume":"1","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00002030-200111090-00008","article-title":"Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil.","volume":"15","author":"de Pinho","year":"2001","journal-title":"AIDS"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.95.23.13881","article-title":"Modeling the impact of global tuberculosis control strategies.","volume":"95","author":"Murray","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/rccm.2508001","article-title":"Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America. Controlling tuberculosis in the United States.","volume":"172","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-11-20210131","first-page":"385","article-title":"Policy statement on preventive therapy against tuberculosis in people living with HIV. Policy Statement.","volume":"74","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.qai.0000152400.36723.85","article-title":"Factors that complicate the treatment of tuberculosis in HIV-infected patients.","volume":"39","author":"Dworkin","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jurban\/79.1.113","article-title":"Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.","volume":"79","author":"Riley","year":"2002","journal-title":"J Urban Health"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199212103272401","article-title":"Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.","volume":"327","author":"Selwyn","year":"1992","journal-title":"N Engl J Med"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archinte.1996.00440080089010","article-title":"Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.","volume":"156","author":"Graham","year":"1996","journal-title":"Arch Intern Med"},{"key":"R14-11-20210131","first-page":"75","article-title":"The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.","volume":"109","author":"Vlahov","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.1992.03480030047035","article-title":"Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.","volume":"267","author":"Graham","year":"1992","journal-title":"JAMA"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1164\/rccm.200405-590OC","article-title":"Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners.","volume":"170","author":"Corbett","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199201233260404","article-title":"An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.","volume":"326","author":"Daley","year":"1992","journal-title":"N Engl J Med"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","article-title":"New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.","volume":"6","author":"Pai","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","article-title":"Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.","volume":"175","author":"Rangaka","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-11-20210131","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"R21-11-20210131","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"R22-11-20210131","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska.","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/510080","article-title":"Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.","volume":"44","author":"Elzi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R26-11-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200812150-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:23:31Z","timestamp":1618039411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200812150-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818d5c1c","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}